This trial is testing a new fetal therapy for babies with severe Congenital Diaphragmatic Hernia (CDH). The goal is to improve neonatal survival rates by increasing lung growth while the baby is still in the womb.
1 Primary · 3 Secondary · Reporting Duration: 6 months after birth
10 Total Participants · 1 Treatment Group
Primary Treatment: Fetoscopic Endoluminal Tracheal Occlusion Surgery · No Placebo Group · N/A
Age 18+ · Female Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: